On the dealmaking front, J&J acquired Halda Therapeutics in a $3.05 billion deal that includes Haldas Riptac cell-death platform and its lead candidate HLD-0915, an oral small-molecule therapy targeting metastatic castration-resistant prostate cancer (mCRPC), along with additional RIPTAC-based programs for other solid tumors
This product is sold exclusively for research purposes only
With advancing age, kidney function can gradually decrease physiologically
Dry mouth may sometimes appear before visible signs develop, making early recognition important
Apply at different times to avoid potential interactions
Pyroxidine also encourages the metabolism of proteins, fats, and carbohydrates, and the normal function of the nervous and immune systems